Empagliflozin Not Linked to Urinary Tract Cancer in T2D ...Middle East

Medscape - News
Empagliflozin Not Linked to Urinary Tract Cancer in T2D
A large, multicountry European study finds that adults with type 2 diabetes who start empagliflozin experience no increased risk for urinary tract cancers, including bladder and renal cancers. Medscape News UK

Hence then, the article about empagliflozin not linked to urinary tract cancer in t2d was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Empagliflozin Not Linked to Urinary Tract Cancer in T2D )

Apple Storegoogle play

Last updated :

Also on site :